Clinical Trial Update: A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy and safety of CS-3150 in Japanese type 2 diabetes patients with microalbuminuria has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• CS-3150 (CS-3150)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Diabetic Nephropathy | Phase 2 | Status: COMPLETED